[1] ICPerMed.The “HAZLO” project: a personalised cardiac
rehabilitation programme[EB/OL]. [2023-10-12].https://www.icpermed.eu/en/hazlo-project.php.
[2] Stenzinger A, Moltzen EK, Winkler E, et al.Implementation of precision medicine in healthcare—A European perspective[J] Intern Med, 2023,294 (4): 437-454.
[3] Navarrabiomed.Proyecto Genoma
NAGEN 1000 [EB/OL].[2023-10-12]. https://www.navarrabiomed.es/es/investigacion/proyectos/nagen1000.
[4] Ron HNS,Vangelis GM,Maurizio S,et al. 5th ESPT CONGRESS on precision medicine and personalised
health seville,Spain-16/18 October
2019[J]. Drug Metab Pers Ther,2019,34(3):33615771.
[5] Stefanicka-Wojtas D, Kurpas D. eHealth and
mHealth in chronic diseases—identification of
barriers, existing solutions, and promoters based on a survey of EU stakeholders involved in
Regions4PerMed (H2020)[J].J Pers Med, 2022, 12 (3):467.
[6] ICPerMed.Navarre Strategy On
Personalised Medicine[EB/OL].(2023-01)[2023-10-12].https://www.icpermed.eu/media/content/ICPERMED%20N
AVARRE%20STRATEGY.pdf.
[7] Navarrabiomed.NAGEN-Mx - Desarrolloy evaluación de una estrategia de cribado personalizado
del cáncer de mama en Navarra[EB/OL].[2023-10-12]. https://www.navarrabiomed.es/es/investigacion/proyectos/nagen-mx-desarrollo-y-evaluacion-de-una-estrategia-de-cribado-personalizado.
[8] ICPerMed.Navarra 1000 Genomes
Project (NAGEN 1000)[EB/OL].[2023-10-12].https://www.icpermed.eu/en/navarra-1000-genomes-project.php.
[9] Golubnitschaja O, Topolcan O, Kucera R,et al.10th Anniversary of the European Association for Predictive, Preventive and Personalised (3P) Medicine - EPMA World Congress Supplement 2020[J].EPMA J ,2020, 11(Suppl 1):S8-S11.
[10] Villagrasa P, Ciruelos E,Llombart-Cussac A,et al.AGATA molecular screening
program: implementing precision medicine in patients
with advanced breast cancer in Spain[J].Annals of Oncology,2015, 26 (suppl 2):ii21-ii22.
[11] Gargallo P, Bautista F, Juan-Ribelles A, et al.Current status of
precision medicine in pediatric oncology in Spain:a
consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP)[J].Clin Transl Oncol,2022, 24(5):809-815.
[12] Rzepecka IK, Konopka B, Podgorska A, et al.EP970PIK3R1 mRNA expression is associated with copy number
alteration in ovarian cancer[J].IJGC,2019,29(Suppl 4):A515-A516.
[13] Duarte AA, Mohsin S, Golubnitschaja O.
Diabetes care in figures: current pitfalls and
future scenario[J]. EPMA J,2018,9(2):125-131.
[14] Polivka J Jr, Polivka J,Pesta M, et al. Risks associated with the stroke predisposition at young age: facts and hypotheses in light of individualized predictive and
preventive approach[J].EPMA J,2019,10(1):81-99.
[15] Gonzalez-Quereda L, Pagola I, Fuentes Prior P, et al.Novel PLEKHG5
mutations in a patient with childhood-onset lower
motor neuron disease[J].Ann Clin Transl Neurol,2021,8(1): 294-299.
[16] Lopez-Lopez D, Loucera C, Carmona R,et al. SMN1 copy-number and sequence variant analysis from next-generation sequencing data[J].Hum Mutat,2020,41(12): 2073-2077.
[17] Peña-Chilet M, Roldán G, Perez-Florido J,et al. CSVS, a crowdsourcing database of the Spanish population genetic
variability[J].Nucleic Acids Res,2021,49(D1):D1130-D1137.
|